AsortinoBeta
DexCom Inc. logo

DXCMDexCom Inc.

NASDAQStockHealthcareMedical Devices🇺🇸 United StatesISIN US2521311074dexcom.com
$87.902.02%
NASDAQ · at close Sep 4, 2026
Tokenized by
Backed Finance logoDinari Inc. logoReality logo
3 issuersOn
Solana logoXLayer logoArbitrum One logoEthereum logo
13 chains

Chart data are delayed by 15 minutes.

1D2.02%
1M+1.10%
3M+21.09%
1Y+8.84%
3Y13.74%
5Y35.18%

Main metrics

$33.17B
$72.64<0.01% of mkt cap
34.74
$2.53
4.8M
1.42
$54.1152-week range$92.59

About DXCM

DexCom Inc. is a medical device company focused on continuous glucose monitoring systems for diabetes and metabolic health. Dexcom develops wearable biosensors, transmitters, receivers, and software that provide real-time glucose readings, trend data, and alerts to help users and clinicians monitor glucose levels without routine fingerstick testing. Its current product lineup includes Dexcom G7, Dexcom G7 15 Day, Dexcom G6, Dexcom ONE+, Stelo, Dexcom Share, and Dexcom Follow, along with digital tools and remote monitoring features that support daily diabetes management. The company serves people with diabetes, adults with prediabetes and type 2 diabetes who do not use insulin, and healthcare professionals across the United States and international markets. Headquartered in San Diego, California, DexCom plays a significant role in the diabetes care technology market through its focus on connected glucose sensing and data-sharing solutions.

Similar products

Abbott Laboratories logo
ABTNYSE
$108.330.42%
Abbott Laboratories
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 15 chains
Bruker Corp. logo
BRKRNASDAQ
$58.501.53%
Bruker Corp.
Reality logo
1 issuer · 2 chains
Boston Scientific Corp. logo
BSXNYSE
$47.80+1.81%
Boston Scientific Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
Edwards Lifesciences Corporation logo
EWNYSE
$89.90+0.13%
Edwards Lifesciences Corporation
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains